Medicare Part D coverage · glecaprevir · RxCUI 1940709
glecaprevir 100 MG / pibrentasvir 40 MG Oral Tablet [Mavyret]
Per the CMS 2026 Part D formulary file, glecaprevir 100 MG / pibrentasvir 40 MG Oral Tablet [Mavyret] is covered by 3,349 Medicare Part D plans (66.3% of enrollable products), averaging Tier 4.2, with prior authorization required on 99.6% of covering formularies.
- 66.3%
- Plan coverage
- 3,349
- Plans covering
- T4.2
- Avg tier
- 99.6%
- Prior auth required
What the CMS Formulary Data Shows for glecaprevir 100 MG / pibrentasvir 40 MG Oral Tablet [Mavyret]
Per the CMS 2026 Part D formulary file, glecaprevir 100 MG / pibrentasvir 40 MG Oral Tablet [Mavyret] (RxNorm concept RXCUI 1940709, generic name glecaprevir) appears on 265 distinct formulary files spanning 3,349 Medicare Part D plan offerings - 66.3% of enrollable Part D products, mid-range placement; shopping across contracts changes access. Tier placement ranges from Tier 1 to Tier 5, with a cross-plan average of Tier 4.2.
Real-world access to glecaprevir 100 MG / pibrentasvir 40 MG Oral Tablet [Mavyret] depends on utilization management as much as tier placement: 99.6% of covering formularies require prior authorization. 0% require step therapy. 54% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 8,771 Part D beneficiaries filled glecaprevir 100 MG / pibrentasvir 40 MG Oral Tablet [Mavyret] in 2023, with total plan-and-beneficiary spending of $232,993,526 and an average per-beneficiary annual cost of $26,564.08. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry glecaprevir 100 MG / pibrentasvir 40 MG Oral Tablet [Mavyret] today.
Coverage Details
- Formularies covering
- 265
- Plans covering
- 3,349
- Coverage rate
- 66.3%
- Tier range
- Tier 1 – Tier 5
- Average tier
- Tier 4, Non-Preferred
Restrictions
- Prior authorization required
- 99.6% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 54% of formularies
2023 Medicare Spending
- Beneficiaries
- 8,771
- Total spending
- $232,993,526
- Avg per beneficiary
- $26,564.08
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering glecaprevir 100 MG / pibrentasvir 40 MG Oral Tablet [Mavyret]
100 Medicare Advantage plans with Part D drug coverage include this drug.
| Plan | Insurer | Tier | PA | Premium | States |
|---|---|---|---|---|---|
| Sentara Community Complete Select (HMO D-SNP) | Sentara Health Plans | T1 | Yes | $0 | VA |
| Sentara Community Complete (HMO D-SNP) | Sentara Health Plans | T1 | Yes | $0 | VA |
| Florida Complete Care-Duals VIP (HMO-POS D-SNP) | Hpmp OF Florida, Inc. | T1 | Yes | $0 | FL |
| ElderServe MAP (HMO D-SNP) | Elderserve Health, Inc. | T1 | Yes | $0 | NY |
| Cooperative Advantage (HMO D-SNP) | Group Health Cooperative OF EAU Claire | T1 | Yes | $0 | WI |
| Longevity Health Plan (PPO I-SNP) | Longevity Health Plan OF NEW Jersey Insurance Comp | T1 | Yes | $0 | NJ |
| Mercy Care Advantage (HMO D-SNP) | Mercy Care | T1 | Yes | $0 | AZ |
| Mercy Care Advantage (HMO D-SNP) | Mercy Care | T1 | Yes | $0 | AZ |
| Mercy Care Advantage (HMO D-SNP) | Mercy Care | T1 | Yes | $0 | AZ |
| Elderplan Plus Long-Term Care (HMO-POS D-SNP) | Elderplan, Inc. | T1 | Yes | $0 | NY |
| Health Choice Pathway (HMO D-SNP) | Health Choice Arizona, Inc. | T1 | Yes | $0 | AZ |
| Healthfirst CompleteCare (HMO D-SNP) | Healthfirst Health Plan, Inc. | T1 | Yes | $0 | NY |
| IMCare Classic (HMO D-SNP) | Itasca Medical Care | T1 | Yes | $0 | MN |
| Johns Hopkins Advantage MD D-SNP (HMO D-SNP) | Hopkins Health Advantage, Inc. | T1 | Yes | $0 | MD |
| MetroPlus UltraCare (HMO D-SNP) | Metroplus Health Plan, Inc. | T1 | Yes | $0 | NY |
| Upper Peninsula Health Plan MI Coordinated Health (HMO D-SNP) | Upper Peninsula Health Plan, LLC | T1 | Yes | $0 | MI |
| CareSource Dual Advantage (HMO D-SNP) | Caresource Georgia Co. | T1 | Yes | $0 | GA |
| Senior Whole Health SCO (HMO D-SNP) | Senior Whole Health, LLC | T1 | Yes | $0 | MA |
| Senior Whole Health SCO NHC (HMO D-SNP) | Senior Whole Health, LLC | T1 | Yes | $0 | MA |
| Molina One Care (HMO D-SNP) | Senior Whole Health, LLC | T1 | Yes | $0 | MA |
Show the next 30 plans
| HAP CareSource MI Coordinated Health (HMO D-SNP) | HAP Caresource | T1 | Yes | $0 | MI |
| PruittHealth Premier D-SNP (HMO D-SNP) | Pruitthealth Premier, Inc. | T1 | Yes | $0 | GA |
| Simpra Advantage Dual Care (PPO D-SNP) | Simpra Advantage, Inc. | T1 | Yes | $0 | AL |
| Gold Coast Health Plan Total Care Advantage (HMO D-SNP) | Ventura County Medi-Cal Managed Care Commission | T1 | Yes | $0 | CA |
| Blue Cross Medicare Advantage Dual Care Plus (HMO D-SNP) | Health Care Service Corporation | T1 | Yes | $0 | NM |
| Blue Cross MA Dual Care Plus Preferred (PPO D-SNP) | Health Care Service Corporation | T1 | Yes | $0 | NM |
| Horizon NJ TotalCare (HMO D-SNP) | Horizon Healthcare OF NEW Jersey, Inc. | T1 | Yes | $0 | NJ |
| SecureBlue (HMO D-SNP) | HMO Minnesota | T1 | Yes | $0 | MN |
| NaviCare (HMO D-SNP) | Fallon Community Health Plan | T1 | Yes | $0 | MA |
| Hamaspik Medicare Choice (HMO D-SNP) | Hamaspik, Inc. | T1 | Yes | $0 | NY |
| SeniorCare Complete (HMO D-SNP) | South Country Health Alliance | T1 | Yes | $0 | MN |
| AbilityCare (HMO D-SNP) | South Country Health Alliance | T1 | Yes | $0 | MN |
| Alameda Alliance Wellness (HMO D-SNP) | Alameda Alliance FOR Health | T1 | Yes | $0 | CA |
| CCA One Care (HMO D-SNP) | Commonwealth Care Alliance, Inc. | T1 | Yes | $0 | MA |
| CCA Senior Care Options (HMO D-SNP) | Commonwealth Care Alliance, Inc. | T1 | Yes | $0 | MA |
| Provider Partners Pennsylvania Community Plan (HMO I-SNP) | Provider Partners Health Plan OF Pennsylvania, Inc | T1 | Yes | $0 | PA |
| Provider Partners North Carolina Community Plan (HMO I-SNP) | Provider Partners Health Plan OF North Carolina | T1 | Yes | $0 | NC |
| Provider Partners Indiana Community Plan (HMO I-SNP) | Provider Partners Health Plan OF Indiana | T1 | Yes | $0 | IN |
| Provider Partners Missouri Community Plan (HMO I-SNP) | Provider Partners Health Plan OF Missouri, Inc. | T1 | Yes | $0 | MO |
| Abilis Health Community (HMO I-SNP) | Signature Advantage, LLC | T1 | Yes | $0 | KY, TN |
| Arkansas Integrated Providers (AIP) Dual Advantage (HMO D-SNP) | Arkansas Superior Select, Inc. | T1 | Yes | $0 | AR |
| Community Care's Partnership Program (HMO D-SNP) | Community Care Health Plan, Inc. | T1 | Yes | $0 | WI |
| Platino Blindao (HMO D-SNP) | Triple S Advantage, Inc. | T1 | Yes | $0 | PR |
| Platino Enlace (HMO D-SNP) | Triple S Advantage, Inc. | T1 | Yes | $0 | PR |
| Platino Advance (HMO D-snp) | Triple S Advantage, Inc. | T1 | Yes | $0 | PR |
| Platino Plus (HMO D-snp) | Triple S Advantage, Inc. | T1 | Yes | $0 | PR |
| Mass General Brigham SCO (HMO D-SNP) | Mass General Brigham Health Plan, Inc | T1 | Yes | $0 | MA |
| Mass General Brigham One Care (HMO D-SNP) | Mass General Brigham Health Plan, Inc | T1 | Yes | $0 | MA |
| Highmark Wholecare Medicare Assured Diamond (HMO D-SNP) | Gateway Health Plan, Inc. | T1 | Yes | $0 | PA |
| Highmark Wholecare Medicare Assured Diamond (HMO D-SNP) | Gateway Health Plan, Inc. | T1 | Yes | $0 | PA |
Showing top 50 of 100 plans.
Frequently Asked Questions
Is glecaprevir 100 MG / pibrentasvir 40 MG Oral Tablet [Mavyret] covered by Medicare Part D?
Yes, glecaprevir 100 MG / pibrentasvir 40 MG Oral Tablet [Mavyret] is covered by 3,349 Medicare Part D plans (66.3% of all Part D formularies).
What tier is glecaprevir 100 MG / pibrentasvir 40 MG Oral Tablet [Mavyret] on Medicare Part D plans?
glecaprevir 100 MG / pibrentasvir 40 MG Oral Tablet [Mavyret] averages Tier 4.2 across Part D plans, ranging from Tier 1 to Tier 5.
Does glecaprevir 100 MG / pibrentasvir 40 MG Oral Tablet [Mavyret] require prior authorization?
99.6% of Part D formularies require prior authorization for glecaprevir 100 MG / pibrentasvir 40 MG Oral Tablet [Mavyret]. Step therapy: 0%. Quantity limits: 54%.
How much does Medicare spend on glecaprevir 100 MG / pibrentasvir 40 MG Oral Tablet [Mavyret]?
In 2023, total Medicare Part D spending on glecaprevir 100 MG / pibrentasvir 40 MG Oral Tablet [Mavyret] was $232,993,526, covering 8,771 beneficiaries. The average spend per beneficiary was $26,564.08.
Read our methodology - how this data is sourced, computed, and verified.
Nationwide similar Part D drugs
Data-derived peers across the CMS Part D formulary extract: nearest average tier placement and nearest prior-authorization rate. Not therapeutic alternatives or same-generic strengths.
Closest average formulary tier
- aripiprazole 2 MG Oral Film [Opipza] T4.2
- 2.4 ML aripiprazole lauroxil 281.3 MG/ML Prefilled Syringe [Aristada] T4.2
- 1 ML benralizumab 30 MG/ML Auto-Injector [Fasenra] T4.2
- {7 (24 HR deutetrabenazine 12 MG Extended Release Oral Tablet [Austedo]) / 7 (24 HR deutetrabenazine 18 MG Extended Release Oral Tablet [Austedo]) / 7 (24 HR deutetrabenazine 24 MG Extended Release Oral Tablet [Austedo]) / 7 (24 HR deutetrabenazine 30 MG Extended Release Oral Tablet [Austedo]) } Pack [Austedo XR Once Daily, 4 Week Titration Pack, 12 MG / 18 MG / 24 MG / 30 MG] T4.2
- abiraterone acetate 500 MG Oral Tablet T4.2
- selexipag 1.6 MG Oral Tablet [Uptravi] T4.2
Similar prior-authorization rate
- granisetron 1 MG Oral Tablet 99.6% PA
- budesonide 0.5 MG/ML Inhalation Suspension 99.6% PA
- dextromethorphan hydrobromide 20 MG / quinidine sulfate 10 MG Oral Capsule [Nuedexta] 99.6% PA
- {4 (apremilast 10 MG Oral Tablet [Otezla]) / 4 (apremilast 20 MG Oral Tablet [Otezla]) / 47 (apremilast 30 MG Oral Tablet [Otezla]) } Pack [Otezla 28-Day 10/20/30 Starter Pack] 99.6% PA
- apremilast 30 MG Oral Tablet [Otezla] 99.6% PA
- {4 (apremilast 10 MG Oral Tablet [Otezla]) / 51 (apremilast 20 MG Oral Tablet [Otezla]) } Pack [Otezla 28-Day 10/20 Starter Pack] 99.6% PA